Astrana Health Reports Revenue Growth and Cost Reductions

By Greg Peters • Tuesday, May 12 11:15 • Permanent Link

Astrana Health’s latest update showed a mix of growth in revenue-related metrics and a notable decline in administrative costs.

General and administrative expense fell to about $19 million in Q1 2026 from roughly $28 million in Q1 2025, a drop of about $9 million. As a share of revenue, G&A improved to 5.9% from 8.9% a year earlier.

The company’s revenue mix continued to shift across its lines of business, with the release highlighting Medicare, Medicaid, commercial and other third-party categories, along with full-risk, partial-risk, capitation, risk pool settlements and incentives, management fees, fee-for-service and other income.

The chart also showed the company’s strategic focus on growing a differentiated provider network, bending the cost curve, and investing in inpatient programs, preventive care and care management through its Care Enablement and Care Partners businesses. Today the company's shares have moved -1.57% to a price of $37.375. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.